Aristotle University Of Thessaloniki (AUTH)
Η συμβολή τού προσδιορισμού του εκπνεόμενου μονοξειδίου του αζώτου στον έλεγχο και την παρακολούθηση παιδιών με χρόνιες πνευμονοπάθειες
Abstract
dc:descriptionAirway inflammation is centrally important in lung diseases. Conversely, direct assessment of airway inflammation using bronchoscopy cannot be used for monitoring due to its invasive nature. Exhaled Nitric Oxide (eNO) is the most extensively studied exhaled marker. Endogenous NO is derived from L-arginine by the enzyme NO synthase (NOS), of which at least three distinct isoforms exist. The inducible form of the NOS (iNOS) is independent of calcium concentration and may be induced by inflammatory cytokines (IL-1β, TNF-α, INF-γ). NOS activation results in the formation of NO and also a variety of nitrogen oxides with a board range of bioactivities, such as nitrate, nitrite and peroxynitrite. The reaction of NO and superoxide forms peroxynitrite. Depending on the concentrations of the reactant and on the redox environment this reaction may be either cytoprotective or cytotoxic. Nitrate and nitrite are additional oxidation products that have been thought of as inert byproducts. S-nitrosothiols (SNOs) may be formed during NOS activation and store and execute bioactivities, such as bronchodilation, cilliary motility, antimicrobial effects and airway-hydration effects. The most widely used method for measurement of exhaled NO (eNO) is chemiluminescence after reaction with ozone. Standardized measurements of eNO provide a completely non-invasive, simple, easy, immediately available and reproducible means of monitoring airway inflammation. The recommended technique for children over 5 years of age is the single- breath-on-line measurement (SBOL). The aim of this study was to evaluate the role of eNO, as a marker of airway inflammation in children lung diseases. We studied asthma, (the most common chronic lung disease), and cystic fibrosis, (the most common fatal inherited disease in childhood). As there is no other study in Greece, we firstly established normal values of eNO among Greek children. Exhaled NO values among 454 healthy children, aged 6-14 years, were measured according to ATS/ERS Guidelines with a chemiluminescence analyzer. Exhaled NO on healthy children is below 14 ppb and depends on age, height, BMI, weight and atopy. The correlation of eNO with atopy and asthma was evaluated. Methods used in everyday clinical practice are not suitable for the assessment of airway inflammation. Symptoms vary widely between individuals and do not accurately reflect the extent of airway inflammation. Pulmonary function tests represent the standard method for assessing asthma, although it is increasingly recognized that such tests do not reflect airway inflammation. Our data, which are in accordance with the data among adults, showed that there is no correlation between eNO levels and lung function tests. It appears that eNO may respond more rapidly than spirometry to changes in allergen exposure and inflammation, making it a more sensitive marker of disease state. Furthermore, eNO is strongly correlated with atopy (total IgE and positive skin prick tests) and bronchial hyper-responsiveness. Asthmatic children have high eNO levels, which show a rapid, dose – dependent response to steroids. Our data showed that adding of a long-acting β2-agonist to inhaled-steroids resulted in a significant reduction in eNO and could be used as an alternative before increasing the dose of inhaled steroids. Montelukast treatment was associated with a significant reduction of eNO, while inhaled steroids resulted in reduction of eNO within normal values. Our study shows clearly the feasibility of eNO monitoring asthma treatment, in paediatric clinical practice. Furthermore, exhaled NO predicted asthma relapse in asymptomatic patients after withdrawal of steroids. The elevation of eNO predicted loss of asthma control in patients having no symptoms or change in spirometry with a sensitivity of 75% and specificity of 95% if an eNO value of 39.5ppb was chosen for cut-off level. Cystic fibrosis is characterized by chronic airway infection and inflammation. Exhaled NO, elevated in most inflammatory lung diseases, was found decreased in CF, suggesting either decreased production or accelerated metabolism. No association of eNO with genotype, infection status, or disease severity was found. Monitoring of eNO is of no benefic among children with CF, but low levels of eNO contribute to discrimination of children with CF. Our study is highly suggestive of the benefit of eNO inflammometry in asthma management. Exhaled NO inflammometry is an easy test which is helpful to detect atopy and asthma and to monitor asthma treatment (to target steroid treatment, to reduce steroids when possible, and to provide less hyper-responsiveness and less inflammation without leading to overall need for more steroids at the group level). Thus, eNO regular measurement offers better asthma management than the conventional lung function tests, with many indications in clinical practice, such as, diagnosis of asthma, prediction of loss of asthma control and monitoring of asthma treatment. This standardized technique is simple, reproducible, acceptable for patients to perform and is ready for routine monitoring. Advances in technology may result in smaller devices that are cheaper and easier to use.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2007
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Χατζηαγόρου, Ελπίς
- Harziagorou, Elpis
Subjects
dc:subject × 16- Μονοξείδιο του αζώτου, Εκπνεόμενο
- Βρογχικό άσθμα
- Κυστική ίνωση
- Παιδιά
- Φλεγμονή αεραγωγών
- Δείκτης φλεγμονής αεραγωγών
- Exhaled nitric oxide
- Asthma
- Cystic fibrosis
- Children
- Airways' inflammation
- Airway inflammation marker
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/19566